H B @ . 1 D P ,B H ,75F ,B ,MA02120, A +B M N 2016 1  1  1  1   D (DOAC )   P  D IN A , ( E), - 1 . E 500,000 .A - ,   - 24 .A E. O  K ( KA), , E . , , , - , , - 57 . , (DOAC ), - , , , E.D - . - , , .DOAC  KA, , , - able pharmacokinetic profles, decreased coagulation moni- , 8 10 . M DOAC  E 11 15 .A   , A ED -  DOAC ( E) has been confned to parenteral agents and oral vitamin K ; ,  (DOAC ), . E . A E - . O   105 , 45 (43%)  60 (57%)  DOAC. most common DOACs initiated. There were signifcantly CC <60 /   DOAC (77.8% . 15%; P < 0.05). There were signifcantly less -   DOAC (15.6% . 55%; P <0.05). P  DOAC (  2.5 I 0 4  . 6 I 5 7 ,  <0.05).P  DOAC (  3 I 24 . 8 I 6 10 ,  <0.05).  DOAC  new onset VTE. Renal and liver function may infuence . DOAC  . 1 3 J Thromb Thrombolysis (2017) 43:74–78 DOI 10.1007/s11239-016-1417-5 Published online: 3 September 2016